Stenting of symptomatic vertebral artery stenosis. A randomised safety and feasibility study - VAST: Vertebral Artery Stenting Trial

niversitair Medisch Centrum Utrecht0 个研究点目标入组 180 人开始时间: 待定最近更新: 2024年6月18日

适应症

试验速览

暂无简介。

•1. TIA or non-disabling ischaemic stroke of the posterior circulation
•2. symptoms must have occurred in the 180 days preceding randomisation
•3. possibility to perform stenting within two weeks after randomisation
•4. stenosis of the vertebral artery of 50% or greater, diagnosed by at least two imaging modalities, and presumed to be of atherosclerotic origin and accessible for endovascular treatment
•5. score on the modified Rankin scale <= 3 (independent in daily activities, although some help may be needed)
•6. age 18 years or older
•7. written informed consent

•1. potential cause of TIA or minor stroke other than stenosis in a vertebral artery
•2. vertebral artery stenosis caused by arterial dissection
•3. previous surgical or endovascular treatment of the stenosis
•4. life expectancy shorter than three years
•5. other serious illness that may confound outcome assessment
•6. severe renal impairment, precluding contrast administration
•7. history of severe allergic reaction to iodonised contrast agent
•8. pregnancy

发起方

niversitair Medisch Centrum Utrecht